After Hours
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours.
Stocks Info
This NASDAQ-listed company operates within the Biotechnology industry segment, falling under the Healthcare sector. The current market capitalization of CytomX Therapeutics Inc is $48.55M. A total of 1.26 million shares were traded on the day, compared to an average of 1.80M shares.
In the most recent transaction, McCarthy Sean A. sold 37,656 shares of CTMX for 0.60 per share on Mar 18 ’25. After the transaction, the CEO now owns 995,195 company shares. In a previous transaction on Mar 18 ’25, Ogden Christopher sold 8,551 shares at 0.60 per share. CTMX shares that Chief Financial Officer owns now total 201,026.
Among the insiders who sold shares, Chu Yu-Waye disposed of 4,025 shares on Mar 18 ’25 at a per-share price of $0.60. This resulted in the Chief Medical Officer holding 135,725 shares of CTMX after the transaction. In another insider transaction, ROWLAND LLOYD A sold 10,203 shares at $0.60 per share on Mar 18 ’25. Company shares held by the General Counsel now total 120,594.
Even though price targets are rarely accurate, they do tend to exert some kind of influence from time to time and are often considered important by markets. In terms of 52-week highs and lows, CTMX has a high of $5.85 and a low of $0.40.
Balance Sheet Annually/Quarterly
In a balance sheet, you can see what assets and liabilities the company has, as well as how much equity investors have invested. These figures can be used to calculate a company’s financial ratios to give investors a better idea of its prospects. CTMX’s latest balance sheet shows that the firm has $305.23M in Cash & Short Term Investments as of fiscal 2021. There were $21.67M in debt and $77.87M in liabilities at the time. Its Book Value Per Share was -$0.01, while its Total Shareholder’s Equity was -$459.00k.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for CTMX is Buy with a score of 4.14.
